The stock price of Privia Health Group Inc (NASDAQ: PRVA) has jumped by 0.74 compared to previous close of 21.50. Despite this, the company has seen a gain of 4.18% in its stock price over the last five trading days. zacks.com reported 2024-11-18 that Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?
Is It Worth Investing in Privia Health Group Inc (NASDAQ: PRVA) Right Now?
Privia Health Group Inc (NASDAQ: PRVA) has a higher price-to-earnings ratio of 211.52x compared to its average ratio. PRVA has 36-month beta value of 0.83. Analysts have mixed views on the stock, with 14 analysts rating it as a “buy,” 8 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for PRVA is 106.24M, and currently, short sellers hold a 5.32% ratio of that float. The average trading volume of PRVA on November 28, 2024 was 784.34K shares.
PRVA’s Market Performance
PRVA’s stock has seen a 4.18% increase for the week, with a 20.53% rise in the past month and a 7.28% gain in the past quarter. The volatility ratio for the week is 3.61%, and the volatility levels for the past 30 days are at 4.53% for Privia Health Group Inc The simple moving average for the past 20 days is 2.63% for PRVA’s stock, with a 14.18% simple moving average for the past 200 days.
Analysts’ Opinion of PRVA
Many brokerage firms have already submitted their reports for PRVA stocks, with KeyBanc Capital Markets repeating the rating for PRVA by listing it as a “Overweight.” The predicted price for PRVA in the upcoming period, according to KeyBanc Capital Markets is $23 based on the research report published on October 11, 2024 of the current year 2024.
Robert W. Baird, on the other hand, stated in their research note that they expect to see PRVA reach a price target of $23. The rating they have provided for PRVA stocks is “Outperform” according to the report published on May 30th, 2024.
Citigroup gave a rating of “Buy” to PRVA, setting the target price at $25 in the report published on April 22nd of the current year.
PRVA Trading at 13.18% from the 50-Day Moving Average
After a stumble in the market that brought PRVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.86% of loss for the given period.
Volatility was left at 4.53%, however, over the last 30 days, the volatility rate increased by 3.61%, as shares surge +15.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.58% upper at present.
During the last 5 trading sessions, PRVA rose by +4.18%, which changed the moving average for the period of 200-days by +6.33% in comparison to the 20-day moving average, which settled at $21.10. In addition, Privia Health Group Inc saw -5.95% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PRVA starting from Mehrotra Parth, who sale 135,142 shares at the price of $18.50 back on Sep 10 ’24. After this action, Mehrotra Parth now owns 247,771 shares of Privia Health Group Inc, valued at $2,500,127 using the latest closing price.
Mehrotra Parth, the Officer of Privia Health Group Inc, proposed sale 135,142 shares at $18.50 during a trade that took place back on Sep 10 ’24, which means that Mehrotra Parth is holding shares at $2,500,719 based on the most recent closing price.
Stock Fundamentals for PRVA
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.09 for the gross margin
The net margin for Privia Health Group Inc stands at 0.01. The total capital return value is set at 0.02. Equity return is now at value 2.21, with 1.20 for asset returns.
Currently, EBITDA for the company is 27.18 million with net debt to EBITDA at -20.42. When we switch over and look at the enterprise to sales, we see a ratio of 1.27. The receivables turnover for the company is 4.2for trailing twelve months and the total asset turnover is 1.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.78.
Conclusion
To put it simply, Privia Health Group Inc (PRVA) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
